Advancing Toward Enhanced Therapy Responses in ER+ Breast Cancer Patients
A groundbreaking study from Baylor College of Medicine pioneers a significant leap toward personalized treatment strategies for estrogen receptor-positive (ER+) breast cancer, the most prevalent...